Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Graft Polymer (GPL)

Price 0.22p on 26-07-2024 at 16:30:02
Change 0.015p 7.32%
Buy 0.23p
Sell 0.21p
Buy / Sell GPL Shares
Last Trade: Unknown 3,000,000.00 at 0.2175p
Day's Volume: 194,724,431
Last Close: 0.22p
Open: 0.205p
ISIN: GB00BMD1Z199
Day's Range 0.19p - 0.235p
52wk Range: 0.11p - 3.15p
Market Capitalisation: £5m
VWAP: 0.218055p
Shares in Issue: 2,296m

Recent Trades History Graft Polymer (GPL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 3,000,000 0.2175p Ordinary
14:35:02 - 26-Jul-24
Sell* 147,908 0.218p Ordinary
15:29:56 - 26-Jul-24
Sell* 543,904 0.2188p Ordinary
15:26:52 - 26-Jul-24
Sell* 1,971,871 0.211p Ordinary
15:26:52 - 26-Jul-24
Sell* 843,168 0.211p Ordinary
15:26:40 - 26-Jul-24
Sell* 960,684 0.2111p Ordinary
15:25:34 - 26-Jul-24
Sell* 235,495 0.2188p Ordinary
15:24:35 - 26-Jul-24
Sell* 950,000 0.2121p Ordinary
15:21:51 - 26-Jul-24
Buy* 1,129,044 0.2198p Ordinary
15:17:25 - 26-Jul-24
Buy* 1,500,000 0.21779p Ordinary
15:15:20 - 26-Jul-24

Share Price History for Graft Polymer

Time period:
to
Date Open High Low Close Volume

Share News for Graft Polymer

EARNINGS AND TRADING: James Cropper posts loss; Arbuthnot profit falls

23rd Jul 2024 16:46

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Graft Polymer files US patent applications as raises equity

11th Jul 2024 16:42

Graft Polymer (UK) PLC - London-based developer and producer of alloyed polymers, biological supplements and drug delivery systems - Files US patent applications for the treatment of substance abuse disorders and mental health disorders using depot drug delivery systems. Graft Polymer says the patent applications aim to leverage its biopolymer expertise in mental health therapy and the treatment of addiction. It is seeking to develop its intellectual property portfolio as part of its new focus on the healthcare industry following the disposal of its industrial plastic manufacturing unit, Graft Polymer DOO. Read More

IN BRIEF: Graft Polymer admits shares to trading

10th Jul 2024 20:16

Graft Polymer (UK) PLC - London-based biopolymer drug delivery systems development company - Says 2.17 billion new ordinary shares, including 1.8 billion placing shares have been admitting to trading on the main market of the London Stock Exchange and to the standard segment of the Financial Conduct Authority's Official List. Total share capital after admission is 2.30 billion. As company holds no ordinary shares in treasury the total number of ordinary shares and voting rights is 2.30 billion. Read More

UK shareholder meetings calendar - next 7 days

21st Jun 2024 15:18

Read More

Graft Polymer in talks to develop drug delivery systems business

7th Jun 2024 13:28

(Alliance News) - Shares in Graft Polymer UK PLC nearly doubled on Friday after it said it drug delivery systems would be a focus area after concluding the first phase of its operational review. Read More

FTSE 100 Latest
Value8,285.71
Change99.36

Login to your account

Forgot Password?

Not Registered